-
oa Endometrial Adenofibroma in a Patient Receiving Toremifene: A Case Report
- Source: Current Medical Imaging, Volume 20, Issue 1, Jan 2024, CMIR-20-E260423216211
-
- 06 Nov 2022
- 28 Mar 2023
- 26 Jun 2023
Abstract
Adenofibroma is a rare benign Müllerian mixed tumor composed of epithelial and mesenchymal cells. This tumor may occasionally be associated with toremifene therapy which is used as an adjuvant drug for breast cancer.
We describe a case of a 55-year-old woman with adenofibroma of the endometrium. This patient was receiving toremifene after surgery and neoadjuvant chemotherapy for breast cancer. She underwent a total abdominal hysterectomy and bilateral salpingectomy. There was no evidence of tumor residual or recurrence at 32 months of MRI follow-up.
In conclusion, we report a rare case of endometrial adenofibroma in a patient receiving toremifene. It must be borne in mind that long-term toremifene therapy may increase the frequency of endometrial neoplasms.